|Pre Doctoral Fellowships|
Pharmaceutics > Pre Doctoral Fellowships
As advances in genomics—the study of genes and their functions — result in the identification and production of functional genes, a quantitative understanding of factors influencing gene therapy delivery will become an increasingly important component of pharmaceutics.
Pharmaceutics is also concerned with understanding the impact of formulation composition and manufacturing / engineering factors on the quality of a dosage form and its physical and chemical stability.
Progress in pharmaceutics research requires the constant entry of well-trained investigators into the field. The PhRMA Foundation recognizes the critical need for such scientists and appreciates that the training of such individuals is both long and expensive, requiring four to five years of study and research. To encourage the entry of more qualified individuals into this area, the PhRMA Foundation program aims at supporting promising students during their thesis research by providing assistance in the form of stipend and funds to cover costs incidental to the training. Applications will be accepted for a minimum of one year and a maximum of two years.
The program is designed for applicants who expect to complete the requirements for the Ph.D. in pharmaceutics in two years or less from the time the fellowship begins. For the purposes of this program, pharmaceutics includes basic pharmaceutics, biopharmaceutics and pharmaceutical technology. The fundamental aspects of pharmacokinetics are not included since these are covered by PhRMA Foundation awards in pharmacology and toxicology. Students in this area are encouraged to submit an application to that program.
The program assumes that the fellows will devote full-time (including summers) to their research. The PhRMA Foundation fellowship may not be used as a supplement to funds from other fellowships or assistantships. However, this does not preclude institutions supplementing a fellowship with their own funds in order to bring the stipend within the normal range of the institution. The focus of the program is to assist in the pre doctoral training of the applicant. It should not be viewed as a program to fund a research project. It should be stressed that the quality of the research proposed will be a major factor in the selection of fellows. The student's success in carrying out a rigorous academic [i.e., course work] program will be another major selection factor. Research projects which extend or develop the proprietary value of specific drug products are not acceptable in this program. This exclusion does not preclude research in which specific drug products are used to test hypotheses which have a general applicability. Applications, however good, which do not meet the aims of the program will be disapproved.
The fellowship program of pre doctoral support is designed to assist full-time, in-residence Ph.D. candidates in pharmaceutics who are enrolled in a school of pharmacy accredited by the American Council on Pharmaceutical Education or the mentor of the applicant must be in an accredited school of pharmacy. The program seeks to support advanced students who will have completed the bulk of their pre-thesis requirements (generally two years of study) and are starting their thesis research by the time the award is activated. Students just starting in graduate school should not apply.To be eligible, applicants must hold a B.S., M.S., or Pharm.D. degree in pharmacy or a related area such as chemistry or biology from an accredited school. A candidate enrolled in a PharmD./Ph.D. program should not be taking required clinical course work or clinical clerkships during the tenure of the fellowship. Also, before an individual is eligible to apply for a PhRMA Foundation award, the applicant must first have a firm commitment from a U.S. university, and must be a U.S. citizen or permanent resident. Applications are to be submitted via the Foundation website and received by September 1, 2013. Applications will not be accepted after the deadline date.
The award is made to the university on behalf of the fellow. The fellowship provides a stipend of $20,000 a year payable quarterly for a minimum of one year and a maximum of two years. Of the $20,000 awarded annually, up to $1,000 a year may be used for incidentals directly associated with the thesis research preparation (e.g., secretarial help, artwork, books, travel, etc.). Awards may be activated beginning January 1, 2014 or on the first day of any month thereafter, up to and including August 1, 2014. The second year of funding, if applicable, will be contingent upon a satisfactory review of the award recipient's progress during the first ten months of funding. A progress report will be due to the Foundation prior to the beginning of the second year of funding. The progress will be assessed by the Pharmaceutics Advisory Committee. The decision will be based on adherence to the goals of the announcement of the overall program, and also in keeping with the originally proposed research on which the award was based. In addition to the progress report, the Foundation must receive certification from the thesis advisor that satisfactory progress is being achieved.
The program, therefore, is designed to provide students stipend support during thesis research. An individual may not simultaneously hold or interrupt any other fellowship providing stipend support during the PhRMA Foundation fellowship. During the tenure of the fellowship, the fellow must be a full-time in-residence student. These funds are not transferable.
The stipend may be continued for up to three months after completion of the requirements for the doctorate, provided that the student remains in the department during this period and has obtained no other stipend or salary support. This provision applies only if there is sufficient time remaining within the agreed upon period of the fellowship and upon specific request to the Foundation, detailing how the time would be used.
Indirect costs are not provided to the institution and PhRMA Foundation grant funds may not be used for this purpose.
1. General Registration Information